A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (Q2861803): Difference between revisions

From MaRDI portal
Import240304020342 (talk | contribs)
Set profile property.
Set OpenAlex properties.
Property / OpenAlex ID
 
Property / OpenAlex ID: W2019966306 / rank
 
Normal rank

Revision as of 00:56, 20 March 2024

scientific article
Language Label Description Also known as
English
A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients
scientific article

    Statements

    A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (English)
    0 references
    0 references
    0 references
    11 November 2013
    0 references
    Bayesian statistics
    0 references
    clinical trial
    0 references
    dose-escalation study
    0 references
    dynamic treatment regime
    0 references
    nonmixture cure model
    0 references

    Identifiers